Close menu

October 27th, 2022 | 12:58 CEST

Buckle up for the comeback?! BYD, Globex Mining, Deutsche Bank

  • Mining
  • Commodities
  • Electromobility
  • Investments
Photo credits:

The markets are currently in a comeback mood. But where will the stock market stars soon shine in their old glory, and where is it only enough for a hit medley in the local disco? In order to be able to judge where the journey for fallen angels on the stock exchange floor can go, it depends first and foremost on the substance. We take a closer look at BYD, Globex Mining and Deutsche Bank and ask: Where is the journey heading?

time to read: 4 minutes | Author: Nico Popp
ISIN: BYD CO. LTD H YC 1 | CNE100000296 , DEUTSCHE BANK AG NA O.N. | DE0005140008 , GLOBEX MINING ENTPRS INC. | CA3799005093

Table of contents:

    Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG
    "[...] China's dominance is one of the reasons why we are so heavily involved in the tungsten market. Here, around 85% of production is in Chinese hands. [...]" Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

    Full interview


    BYD: This hopeful is under a bad star

    The BYD share has lost a lot of ground in recent weeks and months. The carmaker and provider of renewable energy solutions was sold off by the market. The reasons lie less in the Company itself than in the general conditions. According to experts, the new growth figures from China should be treated with caution. Likewise, there is an increasing trend worldwide for camps to form: The West on the one hand and the emerging countries on the other. But the latter scenario must be put into perspective: For China, long-term success will only work with demand from Europe or the USA. The worries that BYD could lose markets in the long term are far-fetched but correspond to the spirit of the times.

    This fact alone could be an argument for taking a closer look at the stock. BYD is considered a very innovative company and offers the business areas of automobiles (approx. 51% of sales), smartphones (40.5%) and batteries/photovoltaics (approx. 7%). BYD wants to take off with its cars in Europe soon. The first tests are promising. Customers get a lot of car for their money, and nothing is cheap in BYD cars, neither under the hood nor in the interior. So the market launch could well be a success. The Company has even greater potential with its photovoltaic activities. Here, too, BYD's solutions are considered to be of high quality. Examples include electricity storage systems for houses. Although the share price has fallen back, this is not a disaster in the long term. However, investors need to consider the geopolitical tensions and keep in mind that even successful companies in authoritarian China can fall by the wayside. In terms of political factors, investors have to make allowances for every stock from China.

    Globex Mining: Facts instead of hope - hundreds of projects at a ridiculous price

    The situation is completely different for Globex Mining. The Canadian company is solid for two reasons: Firstly, it operates from Canada and secondly, it collects promising raw material projects from North America - as if the motto of the first German Chancellor, "No experiments", had become investable. However, being down-to-earth alone will not win you a pot of gold on the stock market. Globex continues to develop its projects and transfers them to joint ventures in order to leverage potential there. Globex Mining has over 200 commodity projects ranging from precious and industrial metals to lithium. Many properties are in an early stage, but in some cases, even feasibility studies and resource estimates are available. Just recently, a resource estimate for the Nordeau gold project was announced.

    The stock of Globex Mining is particularly interesting given the new euphoria on the stock market. Although dirty bombs are being threatened by Russia and economists are declining various recession scenarios up and down, the stock market is flourishing. On the one hand, this may indicate that the worst is already priced in or that the market is gradually factoring in inflation, war economies, and the parallelism of supply chains and economic systems. Even though it may sound absurd, a rally to the point of renewed irrational valuations cannot be ruled out in the event of sudden positive events. This could be peace in Ukraine as well as a freeze of the conflict with less potential for escalation. A declared end to the interest rate turnaround could also allow the markets to breathe a sigh of relief. The turmoil in the bond market is also likely to offer irrational consequences for equities. With its tangible assets in the ground, Globex Mining is a real asset investment. The valuation of around CAD 35 million is nothing short of a joke in light of hundreds of resource projects. While companies like Globex are rarely fairly valued, there could be upside potential in the current environment. Risks at the corporate level or due to the jurisdiction in which Globex operates are almost impossible.

    Deutsche Bank: A real comeback or just a show for former stars

    When it comes to comebacks, the Deutsche Bank share is also currently attracting attention - after all, it has risen by around 20% in the past four weeks. Most recently, the news that UBS's Swiss rival is again attracting more wealthy clients created a good mood in the sector. Added to this is the interest rate turnaround, which could ensure that Deutsche Bank's bread-and-butter business picks up again: Loans are still the best way to make money as a bank. Net interest income accounts for about 43% of Deutsche Bank's gross income. But with the housing market weakening worldwide, it doesn't look like new deals will be plentiful in the coming quarters. In investment banking, much is overshadowed by the "R-word". If the recession comes and lasts, investment bankers are likely to twiddle their thumbs rather than roll over bonuses.

    Deutsche Bank has recently reduced some risks on its balance sheet and should thus be relatively crisis-proof. However, it is still being determined how market developments will affect the share price. Banks are and remain highly complex companies that surprise even experienced analysts. An investment in uncertain times is, therefore, not very obvious. It would be more obvious to bet on the innovative company BYD. But here, China's malus and political risks come into play. In contrast, the Globex Mining share is fundamentally solid but by no means boring. Hundreds of raw material projects at around CAD 35 million seem good value - even without using a calculator.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.


    Commented by Nico Popp on September 28th, 2023 | 09:05 CEST

    Germany - Car Country? The exodus begins: Mercedes-Benz, Volkswagen, First Phosphate

    • Mining
    • phosphate
    • Electromobility
    • Energy

    Cars still play a significant role in Germany. Many households have two vehicles, some even more. However, sales of new cars have weakened recently - the question of whether to buy a combustion engine or an electric vehicle, along with inflation, have deterred many buyers. German brand manufacturers are now being attracted to the US. There, they are enticed by subsidies and an intact market. Find out what the latest plans of Mercedes-Benz, Volkswagen, and others entail and which relatively unknown company could benefit.


    Commented by André Will-Laudien on September 28th, 2023 | 08:05 CEST

    Attention: Extended correction - Buy the right stocks now! Bayer, Viva Gold, TUI, and BASF are on the list!

    • Mining
    • Gold
    • Pharma
    • chemicals
    • travel

    Higher inflation and rising interest rates - this connection should be clear to investors. The interest rate level in Germany has moved from negative territory to 2.77% in the 10-year range, but stocks continued to rise cheerfully. The party led to all-time highs of 16,528 points in July, but the fundamental situation of the companies deteriorated in parallel. Only after repeated warnings from the US Federal Reserve did the explosive NASDAQ also enter a correction. And it continues. Yesterday, the CEO of US investment bank JPMorgan, Dimon, warned that the world may not be prepared for 7% capital market interest rates. He and Dr. Jens Erhardt, the CEO of the asset management company DJE, warn of stronger setbacks on the stock markets. Some stocks have already undergone a strong correction. Here is a brief overview.